Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 119

1.

Tiotropium for treatment of stable COPD: a meta-analysis of clinically relevant outcomes.

Yohannes AM, Willgoss TG, Vestbo J.

Respir Care. 2011 Apr;56(4):477-87. doi: 10.4187/respcare.00852. Epub 2011 Jan 21. Review.

2.

Tiotropium bromide. A review of its use as maintenance therapy in patients with COPD.

Keam SJ, Keating GM.

Treat Respir Med. 2004;3(4):247-68. Review.

PMID:
15350163
3.

Tiotropium in combination with placebo, salmeterol, or fluticasone-salmeterol for treatment of chronic obstructive pulmonary disease: a randomized trial.

Aaron SD, Vandemheen KL, Fergusson D, Maltais F, Bourbeau J, Goldstein R, Balter M, O'Donnell D, McIvor A, Sharma S, Bishop G, Anthony J, Cowie R, Field S, Hirsch A, Hernandez P, Rivington R, Road J, Hoffstein V, Hodder R, Marciniuk D, McCormack D, Fox G, Cox G, Prins HB, Ford G, Bleskie D, Doucette S, Mayers I, Chapman K, Zamel N, FitzGerald M; Canadian Thoracic Society/Canadian Respiratory Clinical Research Consortium.

Ann Intern Med. 2007 Apr 17;146(8):545-55. Epub 2007 Feb 19.

PMID:
17310045
4.

Tiotropium for the treatment of stable chronic obstructive pulmonary disease: a systematic review with meta-analysis.

Rodrigo GJ, Nannini LJ.

Pulm Pharmacol Ther. 2007;20(5):495-502. Epub 2006 Mar 2. Review.

PMID:
16621638
5.

Impact of tiotropium on the course of moderate-to-very severe chronic obstructive pulmonary disease: the UPLIFT trial.

Tashkin DP.

Expert Rev Respir Med. 2010 Jun;4(3):279-89. doi: 10.1586/ers.10.23. Review.

PMID:
20524910
6.

Pharmacologic treatments for chronic obstructive pulmonary disease: a mixed-treatment comparison meta-analysis.

Baker WL, Baker EL, Coleman CI.

Pharmacotherapy. 2009 Aug;29(8):891-905. doi: 10.1592/phco.29.8.891.

PMID:
19637942
7.

The efficacy and safety of tiotropium in Chinese patients with stable chronic obstructive pulmonary disease: a meta-analysis.

Wu Q, Li G, Lei WI, Zhou X.

Respirology. 2009 Jul;14(5):666-74. doi: 10.1111/j.1440-1843.2009.01525.x. Epub 2009 Apr 8.

PMID:
19402836
8.

Benefits and risks of adjunctive inhaled corticosteroids in chronic obstructive pulmonary disease: a meta-analysis.

Sobieraj DM, White CM, Coleman CI.

Clin Ther. 2008 Aug;30(8):1416-25. doi: 10.1016/j.clinthera.2008.08.004.

PMID:
18803985
9.

Outcomes associated with tiotropium use in patients with chronic obstructive pulmonary disease.

Lee TA, Wilke C, Joo M, Stroupe KT, Krishnan JA, Schumock GT, Pickard AS.

Arch Intern Med. 2009 Aug 10;169(15):1403-10. doi: 10.1001/archinternmed.2009.233. Erratum in: Arch Intern Med. 2009 Sep 28;169(17):1568.

PMID:
19667304
10.

Tiotropium: a new, long-acting agent for the management of COPD--a clinical review.

Crutchfield D.

Director. 2004 Summer;12(3):160, 162-4.

PMID:
15323298
11.

Tiotropium: a potential replacement for ipratropium in patients with COPD.

Shukla VK.

Issues Emerg Health Technol. 2002 Jul;(35):1-4.

PMID:
12195603
12.
13.

Tiotropium: a bronchodilator for chronic obstructive pulmonary disease.

Somand H, Remington TL.

Ann Pharmacother. 2005 Sep;39(9):1467-75. Epub 2005 Jul 19. Review.

PMID:
16030078
14.
15.

Role of tiotropium in the treatment of COPD.

Rice KL, Kunisaki KM, Niewoehner DE.

Int J Chron Obstruct Pulmon Dis. 2007;2(2):95-105. Review.

17.

Does tiotropium lower exacerbation and hospitalization frequency in COPD patients: results of a meta-analysis.

Van den Bruel A, Gailly J, Neyt M.

BMC Pulm Med. 2010 Sep 21;10:50. doi: 10.1186/1471-2466-10-50.

18.

Tiotropium for chronic obstructive pulmonary disease.

[No authors listed]

Drug Ther Bull. 2003 Feb;41(2):15-6. Review.

PMID:
12630336
19.
20.

Long-acting bronchodilator therapy for the treatment of chronic obstructive pulmonary disease.

Chen AM, Bollmeier SG, Finnegan PM.

Ann Pharmacother. 2008 Dec;42(12):1832-42. doi: 10.1345/aph.1L250. Epub 2008 Oct 28. Review.

PMID:
18957624

Supplemental Content

Support Center